The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
934
October 28, 1994
View Complete Issue         Table of Contents 2019 
Doxepin Cream for Pruritus
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Doxepin Cream for Pruritus
October 28, 1994 (Issue: 934)
The US Food and Drug Administration has approved the marketing of 5% doxepin hydrochloride cream (Zonalon - GenDerm) for treatment of pruritus due to eczematous dermatoses. Oral doxepin is used as a tricyclic antidepressant (Sinequan, and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Doxepin Cream for Pruritus
Article code: 934b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.